首页> 外文期刊>BMC Family Practice >“I must, and I can live with that”: a thematic analysis of patients’ perspectives on polypharmacy and a digital decision support system for GPs
【24h】

“I must, and I can live with that”: a thematic analysis of patients’ perspectives on polypharmacy and a digital decision support system for GPs

机译:“我必须,我可以忍受”:对PolyPharcacency的观点和GPS数字决策支持系统的专题分析

获取原文
           

摘要

To investigate patients’ perspectives on polypharmacy and the use of a digital decision support system to assist general practitioners (GPs) in performing medication reviews. Qualitative interviews with patients or informal caregivers recruited from participants in a cluster-randomized controlled clinical trial (cRCT). The interviews were transcribed verbatim and analyzed using thematic analysis. We conducted 13 interviews and identified the following seven themes: the patients successfully integrated medication use in their everyday lives, used medication plans, had both good and bad personal experiences with their drugs, regarded their healthcare providers as the main source of medication-related information, discussed medication changes with their GPs, had trusting relationships with them, and viewed the use of digital decision support tools for medication reviews positively. No unwanted adverse effects were reported. Despite drug-related problems, patients appeared to cope well with their medications. They also trusted their GPs, despite acknowledging polypharmacy to be a complex field for them. The use of a digital support system was appreciated and linked to the hope that reasons for selecting specific medication regimens would become more comprehensible. Further research with a more diverse sampling might add more patient perspectives. ClinicalTrials.gov, NCT03430336 . Registered on February 6, 2018.
机译:调查患者对多酚省力的观点以及数字决策支持系统的使用,协助普通从业者(GPS)进行药物评论。与参与者招募的患者或非正式护理人员在聚类随机对照临床试验(CRCT)中的定性访谈。访谈是逐字转录并使用主题分析分析。我们进行了13项访谈并确定了以下七个主题:患者在日常生活中成功综合药物使用,使用药物计划,对其药物的良好和不良的个人经验,将其医疗保健提供者视为相关信息的主要来源。 ,讨论了用他们的GPS进行了改变,对他们有信任关系,并观察了对药物评论的数字决策支持工具的使用。没有报道不受不良的不良反应。尽管有与毒品有关的问题,但患者似乎与他们的药物很好。他们也相信他们的GPS,尽管承认复数是他们的复杂领域。使用数字支持系统的使用并与希望选择特定药物治疗方案的原因更加可理解。通过更多样化的采样进一步研究可能会增加更多的患者观点。 ClinicalTrials.gov,NCT03430336。 2018年2月6日注册。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号